EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Researchers have developed EVScape, a predictive tool that identifies which SARS-CoV-2 strains are most likely to evade host immunity. Utilizing a deep generative model and structural information, the tool offers early warning about viral variants, aiding in the timely development of effective vaccines and treatments.

American Heart Association launches initiative to improve heart failure care

About 6.7 million American adults are living with heart failure (HF), and prevalence is expected to reach more than 8 million by 2030.

January 27, 2025

ViiV takes steps to widen access to HIV prevention drug, but continues to encounter criticism

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and middle-income countries, marking the second time

October 8, 2024

Study reveals potential negative long-term effects of premenopausal bilateral oophorectomy

Increasing concerns regarding potentially harmful long-term effects of premenopausal bilateral oophorectomy (PBO) have caused a decline in the number of women choosing to proactively remove

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.